iOncologi, Inc., has established the Patient Travel Assistance Fund to support patients by covering eligible travel-related expenses associated with participation in clinical trials. To ensure that all funds are used directly for patient support, no indirect costs (overhead, administrative fees, or institutional charges) are allowed.
Funding is strictly allocated for direct patient travel assistance, including transportation, lodging, and other approved expenses. Institutions and organizations administering these funds are required to adhere to this policy, ensuring that 100% of the awarded funds are utilized for patient benefit.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.